SoftSmile's AI-based orthodontic software gets FDA nod

2022 01 21 02 23 4198 2022 01 20 Vision 20220121022957

The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to SoftSmile's Vision artificial intelligence (AI)-based orthodontic software.

The FDA clearance allows SoftSmile to start marketing Vision as a standalone application, the company said.

Vision allows clinicians to create aligner treatment plans in-house and then further develop them using 3D printing. With this technology, clinicians can avoid the use of third-party designers and manufacturers.

Features include an automated segmentation capability, intuitive and comprehensive staging, and a distributed management system, according to SoftSmile.

Vision software. Image courtesy of SoftSmile.Vision software. Image courtesy of SoftSmile.
Page 1 of 18
Next Page